Clinical trials sponsored by Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.

Phase breakdown

Conditions studied

Recruiting trials led by Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.

• A Study of Picankibart in Patients With Active Psoriatic Arthritis
  NCT07295509 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study to Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis
  NCT07265284 · Phase: Phase 3 · Ages: 12 Years to 18 Years · Sex: All (male and female) · 1 location
• IBI354 With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer
  NCT07377643 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid Tumors
  NCT07589205 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. recruiting for?

Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. is the lead sponsor of 4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.